Literature DB >> 19591997

The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.

Mei-Jou Chen1, Hsin-Fu Chen, Shee-Uan Chen, Hong-Nerng Ho, Yu-Shih Yang, Wei-Shiung Yang.   

Abstract

The circulating follistatin and high-sensitivity C-reactive protein (hsCRP) concentrations were significantly higher in 155 Taiwanese women with polycystic ovary syndrome (PCOS) than in 37 healthy controls. Follistatin and hsCRP levels in both the PCOS and control groups were significantly correlated with each other independent of obesity and insulin resistance.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19591997     DOI： 10.1016/j.fertnstert.2009.06.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  11 in total

1.  Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival.

Authors:  Tetsu Miyamoto; Juan Jesús Carrero; Abdul Rashid Qureshi; Björn Anderstam; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2011-02-24       Impact factor: 8.237

Review 2.  Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.

Authors:  Héctor F Escobar-Morreale; Manuel Luque-Ramírez; Frank González
Journal:  Fertil Steril       Date:  2010-12-17       Impact factor: 7.329

3.  Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome.

Authors:  M Yamamoto; S L Feigenbaum; Y Crites; G J Escobar; J Yang; A Ferrara; J C Lo
Journal:  J Perinatol       Date:  2012-01-19       Impact factor: 2.521

4.  Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice.

Authors:  Qi Xie; XingLiang Xiong; Na Xiao; Ke He; Maosheng Chen; Jing Peng; Xian Su; Hua Mei; Yanni Dai; Dan Wei; Ge Lin; Lamei Cheng
Journal:  Stem Cells Int       Date:  2019-09-12       Impact factor: 5.443

5.  Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hossein Rezaie; Mina Darand; Akram Taheri; Nazila Garousi; Bahman Razi; Leonardo Roever; Reza Mohseni; Shimels Hussien Mohammed; Shahab Alizadeh
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

6.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

7.  Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.

Authors:  Joseph S Marino; Jeffrey Iler; Abigail R Dowling; Streamson Chua; Jens C Bruning; Roberto Coppari; Jennifer W Hill
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

8.  Correlation between blood activin levels and clinical parameters of type 2 diabetes.

Authors:  Hui Wu; Michael Wu; Yi Chen; Carolyn A Allan; David J Phillips; Mark P Hedger
Journal:  Exp Diabetes Res       Date:  2012-12-16

9.  Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.

Authors:  L M Turcotte; T E DeFor; L F Newell; C S Cutler; M R Verneris; J Wu; A Howard; M L MacMillan; J H Antin; G M Vercellotti; Ane Slungaard; B R Blazar; D J Weisdorf; A Panoskaltsis-Mortari; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

10.  Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome.

Authors:  Osama Adnan Kensara
Journal:  J Clin Transl Endocrinol       Date:  2018-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.